560
Participants
Start Date
May 2, 2024
Primary Completion Date
December 31, 2026
Study Completion Date
December 31, 2026
IHL-42X Low Dose
Softgel capsule
IHL-42X High Dose
Softgel capsule
Placebo
Softgel capsule
IHL-42X (Optimal Dose)
Softgel capsule
Dronabinol
Softgel capsule
Acetazolamide
Softgel capsule
Placebo
Softgel capsule
Meridian Clinical Research, LLC, Rockville
Advanced Respiratory and Sleep Medicine, PLLC, Huntersville
Velocity Clinical Research - Greenville, Greenville
Velocity Clinical Research - Anderson, Anderson
NeuroTrials Research, Inc., Atlanta
Clinical Neuroscience Solutions, Inc. (CNS Healthcare of Jacksonville), Jacksonville
Clinical Neuroscience Solutions, Inc. (CNS Healthcare of Orlando), Orlando
Clinical Neuroscience Solutions, Inc. (CNS Healthcare of Memphis), Memphis
CTI Clinical Trial and Consulting Services, Cincinnati
Tandem Clinical Research, LLC, Marrero
FutureSearch Trials, Austin
CenExel CNS- Los Alamitos, Long Beach
Exalt Clinical Research, Chula Vista
Pacific Clinical Research Medical Group, Upland
Teradan Clinical Trials, Valrico
Palm Beach Research Center, West Palm Beach
Centennial Medical Group, Elkridge
Henderson Clinical Trials,LLC, Henderson
Intrepid Research, Cincinnati
FutureSearch Trials of Dallas, LP, Dallas
Lead Sponsor
Incannex Healthcare Ltd
INDUSTRY